Patients with severe COVID-19 show markedly reduced CD4+ and CD8+ T lymphocyte levels compared to patients with moderate COVID-19, and the blood of patients with both severe or moderate COVID-19 is deficient in CD4+ CD25+ CD127lo and CD45RA+ regulatory T lymphocytes [34]. This evidence concerns the gene CD8A and COVID-19.